Loading...
Market
What will be the outcome of Neuralink's first phase of the N1 Implant trial by Dec 31, 2024?
2
Resolution / Starting Odds
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful • 25%
Trial halted • 25%
Neuralink's official trial results publication
Story
Neuralink Launches Trial of N1 Brain Implant to Control Robotic Arm in Paralyzed Patients
Nov 25, 2024, 07:45 PM
Neuralink announced the launch of a new feasibility study, named 'CONVOY', to extend brain-computer interface (BCI) control using the N1 Implant to an investigational assistive robotic arm. The study aims to evaluate the safety and effectiveness of the implant in patients with quadriplegia, allowing them to control external devices with their thoughts. This development represents an important step towards restoring physical freedom to individuals with paralysis.
View original story
Similar markets
Full success • 25%
Partial success • 25%
No success • 25%
Trial discontinued • 25%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful due to technical issues • 25%
Unsuccessful due to patient complications • 25%
Significant improvement in mobility • 25%
Moderate improvement in mobility • 25%
No improvement in mobility • 25%
Trial inconclusive • 25%
Successful with significant findings • 25%
Successful with limited findings • 25%
Unsuccessful • 25%
Indeterminate • 25%
Significant improvement in vision • 25%
Moderate improvement in vision • 25%
No noticeable improvement • 25%
Negative side effects • 25%
Yes • 50%
No • 50%
Recruitment completion • 25%
Initial results published • 25%
Trial expansion approved • 25%
Trial discontinued • 25%